Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
NeuroBo will focus on advancing the company’s clinical-stage pipeline for neurodegenerative diseases.
Lead Product(s): NB-01
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Phase IIProduct Type: Undisclosed
Recipient: NeuroBo Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger January 10, 2020